1. Home
  2. CMTL vs IPHA Comparison

CMTL vs IPHA Comparison

Compare CMTL & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

HOLD

Current Price

$5.60

Market Cap

162.1M

Sector

Technology

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.74

Market Cap

169.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTL
IPHA
Founded
1967
1999
Country
United States
France
Employees
1385
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.1M
169.6M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
CMTL
IPHA
Price
$5.60
$1.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$5.00
AVG Volume (30 Days)
258.5K
19.8K
Earning Date
03-16-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$499,528,000.00
N/A
Revenue This Year
N/A
$28.31
Revenue Next Year
$1.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$1.57
52 Week High
$6.21
$2.63

Technical Indicators

Market Signals
Indicator
CMTL
IPHA
Relative Strength Index (RSI) 47.04 N/A
Support Level $5.34 N/A
Resistance Level $6.15 N/A
Average True Range (ATR) 0.37 0.00
MACD -0.08 0.00
Stochastic Oscillator 40.00 0.00

Price Performance

Historical Comparison
CMTL
IPHA

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: